Company Description
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States.
It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients.
It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions.
The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine.
The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules.
The company is based in Vancouver, Canada.
| Country | Canada |
| Founded | 2007 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 89 |
| CEO | Zaki Rakib |
Contact Details
Address: 1140-625 Howe Street Vancouver, BC V6C 2T6 Canada | |
| Phone | 604 689 5722 |
| Website | bioharvest.com |
Stock Details
| Ticker Symbol | BHST |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001723464 |
| CUSIP Number | 09076J207 |
| ISIN Number | CA09076J2074 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Zaki Rakib Ph.D. | Co-Founder, Chief Executive Officer, Executive Chairman and President |
| Dr. Yoheved Hagay Ph.D. | Co-Founder and Chief Technology Officer |
| Bar Dichter | Chief Financial Officer |
| Dr. Ilana Belzer Ph.D. | Chief Operating Officer |
| David K. Ryan | Vice President of Investor Relations and Secretary |
| Jared Turner | Chief Sales Officer |
| Dr. Malkit Azachi Ph.D. | Vice President of Research and Development |
| Michal Abargel Sapir | Vice President of Regulatory Affairs |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 18, 2026 | 6-K | Report of foreign issuer |
| May 28, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 14, 2026 | 6-K | Report of foreign issuer |
| May 13, 2026 | 6-K | Report of foreign issuer |
| May 12, 2026 | 6-K | Report of foreign issuer |
| May 11, 2026 | 6-K | Report of foreign issuer |
| May 1, 2026 | 6-K | Report of foreign issuer |
| Apr 29, 2026 | 6-K | Report of foreign issuer |